Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma

Investigators from the National Institutes of Health (NIH) report 2 partial responses (PR) in 3 peripheral T-cell lymphoma (PTCL) patients and 1 PR in 2 double-hit diffuse large b-cell lymphoma (DH-DLBCL) patients in ongoing dose-escalation trial of enitociclib in combination with venetoclax and…#nih #vincerx #paloalto #vincerxpharma #cdk9 #ahmedhamdy #nonhodgkin #ianflinn #phd #vip236
Source: Reuters: Health - Category: Consumer Health News Source Type: news